Clinical and epidemiological features of corpus uteri cancer


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. Malignant neoplasms of the reproductive system dominate the structure of cancer incidence in women in the Russian Federation. In the structure of oncogynecological diseases, uterine body cancer (UBC) leads the way. The purpose of the study: to analyze the dynamics of UBC incidence in the Omsk region in comparison with data for the Russian Federation for the period 20022018 to determine the priorities of cancer prevention. Results: there was a moderate tendency to increase the incidence of UBC in the region (Rg. =+1.8%; p<0.001) and for the Russian Federation (Rg. =+1.7%; p<0.001). The maximum percentage was 60-69 years old (32.3%). There was a moderate tendency to increase UBC among women 30-39 years old, and in the group of women 35-39 years old there was a pronounced tendency to increase the incidence (Rg.=+5.6%; p<0.05). The article presents the epidemiological features of UBC in comparison with cervical cancer in the region: the increase in the incidence of UBC (Rg.=+1.8%) and the stability of the indicator at cervical cancer (Rg.=+0.05%), the tendency to rejuvenate both locations of cancer. Conclusion: in the Omsk region, there is a unidirectional increase in the incidence of UBC with the Russian Federation, a tendency to «rejuvenate» the disease, which dictates the need for cancer prevention in the practice of an obstetrician-gynecologist.

Full Text

Restricted Access

About the authors

T. Klinyshkova

Omsk State Medical University

Email: klin_tatyana@mail.ru

References

  1. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность) Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой / М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018. илл. 250 с.
  2. Cancer Today - IARC, World Health Organization: GLOBOCAN 2018. URL: https://gco.iarc.fr/today/home
  3. Клинышкова Т.В., Турчанинов Д.В., Самосудова И.Б. Эпидемиологические аспекты цервикального предрака у женского населения г. Омска (по материалам выборочного исследования) // Росс. вестн. акушера-гинеколога. - 2013; 4: 13-7
  4. Думановская М.Р., Чернуха Г.Е., Асатурова А. В. и др. Частота выявления и структура гиперплазии эндометрия в различные возрастные периоды // Акушерство и гинекология. - 2015; 3: 40-4
  5. Клинышкова Т.В., Турчанинов Д.В., Буян М.С. Эпидемиологические аспекты рака шейки матки в Омской области // Акушерство и гинекология. - 2018; 3: 102-8
  6. Marnach M., Butler K., Henry M. et al. Oral Progestogens Versus Levonorge strel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia // J. Wom. Health (Larchmt). - 2017; 26 (4): 368-73. DOI: 10.1089/ jwh.2016.5774.
  7. Gallos I., Shehmar M., Thangaratinam S. et al. Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. // Аm. J. Obstet. Gynecol. - 2010; 203 (6): 547.e1-10. doi: 10.1016/j.ajog.2010.07.037
  8. Gallos I., Krishan P., Shehmar M. et al. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study. // Hum. Reprod. - 2013; 28 (11): 2966-71. doi: 10.1093/humrep/det320.
  9. Management of Endometrial Hyperplasia. Green-top Guideline No. 67 RCOG/ BSGE Joint Guideline February 2016. URL: https://www.rcog.org.uk/globalassets/ documents/guidelines/green-top-guidelines/gtg_67_endometrial_hyperplasia.pdf
  10. rbo A., Arnes M., Vereide A. et al. Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens // BJOG. - 2016; 123 (9): 1512-9. doi: 10.1111/1471-0528.13763.
  11. Тихомиров А.Л. Обоснование использования комбинированных оральных контрацептивов для профилактики рецидивов типичных гиперплазий эндометрия // Гинекология. - 2018; 20 (4): 26-8
  12. Гиперпластические процессы эндометрия. Гинекология. Национальное руководство / М.:, 2017; с. 303-8

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies